NYSEAMERICAN:ELMD Electromed (ELMD) Stock Forecast, Price & News $11.77 -0.47 (-3.84%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$11.76▼$12.1050-Day Range$10.03▼$13.6052-Week Range$8.75▼$13.84Volume6,811 shsAverage Volume13,219 shsMarket Capitalization$100.75 millionP/E Ratio42.04Dividend YieldN/APrice Target$20.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Electromed MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside74.2% Upside$20.50 Price TargetShort InterestHealthy0.62% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.98 out of 5 stars 3.5 Analyst's Opinion Consensus RatingElectromed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $20.50, Electromed has a forecasted upside of 74.2% from its current price of $11.77.Amount of Analyst CoverageElectromed has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.62% of the float of Electromed has been sold short.Short Interest Ratio / Days to CoverElectromed has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Electromed has recently decreased by 1.75%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ELMD. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 5 news articles for Electromed this week, compared to 1 article on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have not sold or bought any company stock.Percentage Held by Insiders12.30% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.95% of the stock of Electromed is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 42.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.81.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 42.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 92.35.Price to Book Value per Share RatioElectromed has a P/B Ratio of 2.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Electromed (NYSEAMERICAN:ELMD) StockElectromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.Read More Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Email Address ELMD Stock News HeadlinesJune 9, 2023 | bizjournals.comElectromed appoints Jim Cunniff new CEOJune 6, 2023 | finance.yahoo.comElectromed, Inc. to Participate in the Sidoti Summer Small Cap ConferenceJune 9, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.June 5, 2023 | marketwatch.comElectromed Names Jim Cunniff President, CEOJune 5, 2023 | msn.comElectromed appoints CEOJune 5, 2023 | markets.businessinsider.comElectromed CEO Kathleen Skarvan Steps Down, Names Jim Cunniff SuccessorMay 24, 2023 | americanbankingnews.comElectromed (NYSE:ELMD) Raised to Strong-Buy at StockNews.comMay 20, 2023 | msn.comElectromed: May Reversal Vindicating Long-Term Buy ThesisJune 9, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 15, 2023 | americanbankingnews.comElectromed (NYSE:ELMD) Rating Lowered to Buy at StockNews.comMay 14, 2023 | americanbankingnews.comElectromed (NYSEAMERICAN:ELMD) Stock Crosses Above 200 Day Moving Average of $10.82May 13, 2023 | americanbankingnews.comElectromed (NYSEAMERICAN:ELMD) Downgraded to Buy at StockNews.comMay 13, 2023 | msn.comEF Hutton Reiterates Electromed (ELMD) Buy RecommendationMay 11, 2023 | msn.comRecap: Electromed Q3 EarningsMay 10, 2023 | finance.yahoo.comElectromed, Inc. Announces Fiscal 2023 Third Quarter ResultsApril 29, 2023 | finance.yahoo.comElectromed, Inc. to Participate in the Inaugural EF Hutton Global ConferenceApril 17, 2023 | americanbankingnews.comHead to Head Review: Sonova (OTCMKTS:SONVY) vs. (NYSE:ELMD)April 6, 2023 | americanbankingnews.comElectromed (NYSE:ELMD) Coverage Initiated at StockNews.comMarch 30, 2023 | americanbankingnews.comElectromed (NYSE:ELMD) Earns Strong-Buy Rating from Analysts at StockNews.comMarch 22, 2023 | americanbankingnews.comElectromed (NYSE:ELMD) Research Coverage Started at StockNews.comFebruary 14, 2023 | msn.comEarnings Scheduled For February 14, 2023February 14, 2023 | msn.comElectromed's Earnings: A PreviewDecember 3, 2022 | seekingalpha.comElectromed: SmartVest Clearance Adds Alpha Opportunity, Rate BuyNovember 30, 2022 | marketwatch.comElectromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance GeneratorNovember 11, 2022 | seekingalpha.comElectromed, Inc. (ELMD) Q1 2023 Earnings Call TranscriptOctober 24, 2022 | finance.yahoo.comElectromed, Inc. Appoints Brad Nagel as Chief Financial OfficerOctober 24, 2022 | marketwatch.comElectromed, Inc. Appoints Brad Nagel As Chief Financial Officer >ELMDSee More Headlines ELMD Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ELMD Company Calendar Last Earnings11/09/2021Today6/09/2023Fiscal Year End6/30/2023Next Earnings (Estimated)8/21/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNYSEAMERICAN:ELMD Previous SymbolNYSEMKT:ELMD CUSIPN/A CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees132Year FoundedN/APrice Target and Rating Average Stock Price Forecast$20.50 High Stock Price Forecast$26.00 Low Stock Price Forecast$15.00 Forecasted Upside/Downside+74.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.28 Trailing P/E Ratio42.04 Forward P/E RatioN/A P/E GrowthN/ANet Income$2.31 million Net Margins5.50% Pretax Margin6.67% Return on Equity7.18% Return on Assets6.07% Debt Debt-to-Equity RatioN/A Current Ratio5.48 Quick Ratio4.94 Sales & Book Value Annual Sales$41.66 million Price / Sales2.42 Cash Flow$0.32 per share Price / Cash Flow36.23 Book Value$4.00 per share Price / Book2.94Miscellaneous Outstanding Shares8,560,000Free Float7,508,000Market Cap$100.75 million OptionableNot Optionable Beta0.42 Key ExecutivesKathleen S. SkarvanPresident, Chief Executive Officer & DirectorBradley M. NagelCFO, CAO, Secretary & TreasurerChristopher HollandChief Commercial OfficerKristine OwataVice President-Reimbursement & Payer RelationsDiane M. KaufmanVice President-Human ResourcesKey CompetitorsFONARNASDAQ:FONRViewRayNASDAQ:VRAYBioSig TechnologiesNASDAQ:BSGMHyperfineNASDAQ:HYPRVivani MedicalNASDAQ:VANIView All CompetitorsInstitutional OwnershipPunch & Associates Investment Management Inc.Bought 950 shares on 5/15/2023Ownership: 4.906%Dimensional Fund Advisors LPSold 6,854 shares on 5/12/2023Ownership: 3.274%Renaissance Technologies LLCBought 10,700 shares on 5/12/2023Ownership: 0.629%BlackRock Inc.Sold 7,817 shares on 5/12/2023Ownership: 0.224%Corsair Capital Management L.P.Bought 2,152 shares on 5/12/2023Ownership: 0.195%View All Institutional Transactions ELMD Stock - Frequently Asked Questions Should I buy or sell Electromed stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ELMD shares. View ELMD analyst ratings or view top-rated stocks. What is Electromed's stock price forecast for 2023? 3 Wall Street research analysts have issued 12 month target prices for Electromed's shares. Their ELMD share price forecasts range from $15.00 to $26.00. On average, they predict the company's stock price to reach $20.50 in the next twelve months. This suggests a possible upside of 74.2% from the stock's current price. View analysts price targets for ELMD or view top-rated stocks among Wall Street analysts. How have ELMD shares performed in 2023? Electromed's stock was trading at $10.4350 at the beginning of 2023. Since then, ELMD stock has increased by 12.8% and is now trading at $11.77. View the best growth stocks for 2023 here. Are investors shorting Electromed? Electromed saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 39,900 shares, an increase of 12.1% from the April 15th total of 35,600 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 2.5 days. Currently, 0.6% of the shares of the company are sold short. View Electromed's Short Interest. When is Electromed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023. View our ELMD earnings forecast. How were Electromed's earnings last quarter? Electromed, Inc. (NYSEAMERICAN:ELMD) announced its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by $0.01. The medical equipment provider had revenue of $10 million for the quarter, compared to analyst estimates of $9 million. Electromed had a net margin of 5.50% and a trailing twelve-month return on equity of 7.18%. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE). What is Electromed's stock symbol? Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD." Who are Electromed's major shareholders? Electromed's stock is owned by a number of retail and institutional investors. Top institutional investors include Punch & Associates Investment Management Inc. (4.91%), Dimensional Fund Advisors LP (3.27%), Hunter Associates Investment Management LLC (0.86%), Renaissance Technologies LLC (0.63%), Annex Advisory Services LLC (0.27%) and BlackRock Inc. (0.22%). Insiders that own company stock include A Jones Lee, Michael Joseph Maccourt and Stephen H Craney. View institutional ownership trends. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Electromed's stock price today? One share of ELMD stock can currently be purchased for approximately $11.77. How much money does Electromed make? Electromed (NYSEAMERICAN:ELMD) has a market capitalization of $100.75 million and generates $41.66 million in revenue each year. The medical equipment provider earns $2.31 million in net income (profit) each year or $0.28 on an earnings per share basis. How many employees does Electromed have? The company employs 132 workers across the globe. How can I contact Electromed? Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The official website for the company is smartvest.com. The medical equipment provider can be reached via phone at (952) 758-9299, via email at investorrelations@electromed.com, or via fax at 866-758-5077. This page (NYSEAMERICAN:ELMD) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.